quinazolines has been researched along with Cushing Syndrome in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baudry, C; Groussin, L; Paepegaey, AC | 1 |
| Balis, FM; Derdak, J; Fox, E; Kebebew, E; Lodish, MB; Nella, AA; Quezado, MM; Stratakis, CA; Whitcomb, PO; Widemann, BC | 1 |
| Bao, WM; Chen, H; Chen, JH; Fu, CW; Geng, DY; He, WQ; Hu, RG; Huang, CX; Huang, S; Ji, J; Li, SQ; Li, YM; Li, ZQ; Liu, YC; Ma, ZY; Mao, Y; Pan, L; Peng, H; Qiao, ND; Qin, XL; Qiu, HJ; Shen, JW; Shen, M; Shi, YY; Shi, ZF; Shou, XF; Song, ZJ; Tang, QS; Tang, WJ; Wang, QZ; Wang, T; Wang, Y; Wang, YF; Wen, ZJ; Xie, R; Ye, HY; Ye, Z; Zhang, QL; Zhang, Y; Zhang, YC; Zhang, ZY; Zhao, Y; Zheng, J; Zhou, DZ; Zhou, J; Zhou, LF | 1 |
| Bueno, F; Cross, G; Lucas, S; Pitoia, F; Schmidt, A | 1 |
| Alifano, M; Bienvenu-Perrard, M; Bricaire, L; Burnichon, N; Cochand-Priollet, B; Groussin, L; Lahlou, N; Louiset, E; Paepegaey, AC; Sarfati, PO | 1 |
| Biller, BM; Tritos, NA | 1 |
1 review(s) available for quinazolines and Cushing Syndrome
| Article | Year |
|---|---|
Advances in medical therapies for Cushing's syndrome.
Topics: Animals; Bexarotene; Cushing Syndrome; Etomidate; Humans; Ketoconazole; Lapatinib; Metyrapone; Mifepristone; Mitotane; Quinazolines; Somatostatin; Tetrahydronaphthalenes | 2012 |
5 other study(ies) available for quinazolines and Cushing Syndrome
| Article | Year |
|---|---|
Reversal of Cushing's syndrome by vandetanib in medullary thyroid carcinoma.
Topics: Adrenocorticotropic Hormone; Calcitonin; Carcinoma, Neuroendocrine; Cushing Syndrome; Deamino Arginine Vasopressin; Humans; Lymphatic Metastasis; Male; Middle Aged; Paraneoplastic Syndromes; Piperidines; Quinazolines; Receptors, Vascular Endothelial Growth Factor; Thyroid Neoplasms | 2013 |
Vandetanib successfully controls medullary thyroid cancer-related Cushing syndrome in an adolescent patient.
Topics: Adolescent; Adrenocorticotropic Hormone; Carcinoma, Neuroendocrine; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cushing Syndrome; Humans; Male; Multiple Endocrine Neoplasia Type 2b; Neoplasms, Second Primary; Piperidines; Protein-Tyrosine Kinases; Quinazolines; Thyroid Neoplasms | 2014 |
Recurrent gain-of-function USP8 mutations in Cushing's disease.
Topics: 14-3-3 Proteins; ACTH-Secreting Pituitary Adenoma; Adolescent; Adrenocorticotropic Hormone; Adult; Base Sequence; Cushing Syndrome; Endopeptidases; Endosomal Sorting Complexes Required for Transport; ErbB Receptors; Exome; Female; Gefitinib; Humans; Male; Middle Aged; Pro-Opiomelanocortin; Protein Binding; Protein Kinase Inhibitors; Quinazolines; RNA Interference; RNA, Small Interfering; Sequence Analysis, DNA; Ubiquitin Thiolesterase; Young Adult | 2015 |
Rapid response of hypercortisolism to vandetanib treatment in a patient with advanced medullary thyroid cancer and ectopic Cushing syndrome.
Topics: Adult; Carcinoma, Neuroendocrine; Cushing Syndrome; Disease Progression; Female; Humans; Neoplasm Staging; Piperidines; Quinazolines; Thyroid Neoplasms; Treatment Outcome | 2015 |
Long-Term Control of Hypercortisolism by Vandetanib in a Case of Medullary Thyroid Carcinoma with a Somatic RET Mutation.
Topics: Calcitonin; Carcinoma, Neuroendocrine; Cushing Syndrome; Cytoreduction Surgical Procedures; Humans; Hydrocortisone; Male; Middle Aged; Neck Dissection; Piperidines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-ret; Quinazolines; Thyroid Neoplasms; Thyroidectomy | 2017 |